Sanofi-aventis, the fourth biggest pharmaceutical company, has shown an interest in acquiring the pharmaceutical division of Solvay, according to the Financial Times. The Belgium-based company’s shares rose yesterday on rumours that a large European company was assessing the chemicals and pharmaceuticals group.